Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8124690rdf:typepubmed:Citationlld:pubmed
pubmed-article:8124690lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:8124690lifeskim:mentionsumls-concept:C0553580lld:lifeskim
pubmed-article:8124690lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:8124690lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:8124690lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:8124690lifeskim:mentionsumls-concept:C0037791lld:lifeskim
pubmed-article:8124690lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:8124690lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:8124690pubmed:issue3lld:pubmed
pubmed-article:8124690pubmed:dateCreated1994-4-12lld:pubmed
pubmed-article:8124690pubmed:abstractTextA selection of 16 monoclonal antibodies has been produced against a fresh Ewing's sarcoma (ES) tumor mixed with a permanent ES cell line. The majority of antibodies identify an 80-kDa molecule, which is not detected on healthy tissues except on certain cultured monocytes. One antibody recognizes the CD2 ligand MIC2 and 2 antibodies (numbers 13 and 16) define a higher-molecular-mass antigen. Antibody 16 is also expressed on mesenchymal fibroblasts of bone marrow or fetal origin. Tumor-specific antigen expression is potentially linked to the chromosome 22 abnormality described in Ewing's sarcoma, products altered expression in tumors with the chromosome 11/22 translocation has not been shown. The putative chimeric protein on chromosome 11 is apparently not expressed to a great extent, as tested by Northern blotting; however, the fusion protein initiated on chromosome 22 and ending on chromosome 11 is readily seen on Northern blots. The altered expression of a number of cellular genes in addition to a novel gene product(s) originating from translocation events were expected to be identified by monoclonal antibodies selected by their unique binding pattern to Ewing's sarcoma (ES) cells.lld:pubmed
pubmed-article:8124690pubmed:languageenglld:pubmed
pubmed-article:8124690pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8124690pubmed:citationSubsetIMlld:pubmed
pubmed-article:8124690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8124690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8124690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8124690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8124690pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8124690pubmed:statusMEDLINElld:pubmed
pubmed-article:8124690pubmed:monthMarlld:pubmed
pubmed-article:8124690pubmed:issn0340-7004lld:pubmed
pubmed-article:8124690pubmed:authorpubmed-author:BorchardFFlld:pubmed
pubmed-article:8124690pubmed:authorpubmed-author:GöbelUUlld:pubmed
pubmed-article:8124690pubmed:authorpubmed-author:JürgensHHlld:pubmed
pubmed-article:8124690pubmed:authorpubmed-author:SchneiderE...lld:pubmed
pubmed-article:8124690pubmed:authorpubmed-author:ShiL RLRlld:pubmed
pubmed-article:8124690pubmed:authorpubmed-author:EichelbauerDDlld:pubmed
pubmed-article:8124690pubmed:issnTypePrintlld:pubmed
pubmed-article:8124690pubmed:volume38lld:pubmed
pubmed-article:8124690pubmed:ownerNLMlld:pubmed
pubmed-article:8124690pubmed:authorsCompleteYlld:pubmed
pubmed-article:8124690pubmed:pagination208-13lld:pubmed
pubmed-article:8124690pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:8124690pubmed:meshHeadingpubmed-meshheading:8124690-...lld:pubmed
pubmed-article:8124690pubmed:meshHeadingpubmed-meshheading:8124690-...lld:pubmed
pubmed-article:8124690pubmed:meshHeadingpubmed-meshheading:8124690-...lld:pubmed
pubmed-article:8124690pubmed:meshHeadingpubmed-meshheading:8124690-...lld:pubmed
pubmed-article:8124690pubmed:meshHeadingpubmed-meshheading:8124690-...lld:pubmed
pubmed-article:8124690pubmed:meshHeadingpubmed-meshheading:8124690-...lld:pubmed
pubmed-article:8124690pubmed:meshHeadingpubmed-meshheading:8124690-...lld:pubmed
pubmed-article:8124690pubmed:meshHeadingpubmed-meshheading:8124690-...lld:pubmed
pubmed-article:8124690pubmed:meshHeadingpubmed-meshheading:8124690-...lld:pubmed
pubmed-article:8124690pubmed:meshHeadingpubmed-meshheading:8124690-...lld:pubmed
pubmed-article:8124690pubmed:meshHeadingpubmed-meshheading:8124690-...lld:pubmed
pubmed-article:8124690pubmed:meshHeadingpubmed-meshheading:8124690-...lld:pubmed
pubmed-article:8124690pubmed:year1994lld:pubmed
pubmed-article:8124690pubmed:articleTitleSpecificity and function of monoclonal antibodies directed against Ewing sarcoma cells.lld:pubmed
pubmed-article:8124690pubmed:affiliationImmunology Laboratory, Institute of Blood Coagulation and Transfusion Medicine, University of Düsseldorf, Germany.lld:pubmed
pubmed-article:8124690pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8124690pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed